Issue: Vol. 2, No. 20 - November 18, 2015

Go Back to Medtech Strategist Issue Archive
Table of Contents – The MedTech Strategist, Vol. 2, No. 20, November 18, 2015 (40 Pages):
- Executive Interview – “J&J Plots the Future of Medtech Innovation,” by David Cassak
- Neuro-Diagnostics – “Managing Concussion: Sports and Device Industries Collaborate to Bring New Technologies to Fruition,” by Mary Thompson
- Commercial Strategies – “Cerapedics: A PMA First Opens Up New Opportunities in Cervical Spine Osteobiologics,” by Wendy Diller
- Outside Opinion – “When Considering a Merger, Ask Why,” by Brian Chapman and Matt Scheitlin, ZS Associates
- Start-Ups to Watch – “Helius Medical Technologies: Using Neurostimulation to Help Retrain the Brain,” by Mary Thompson
- Start-Ups to Watch – “Lungpacer: Catheter-based Pacing Dramatically Improves Mechanical Ventilation,” by Mary Stuart
Articles in This Issue
“Executive Interview – J&J Plots the Future of Medtech Innovation,” by David Cassak
Article Categories:Biopharma/Biomaterials · Business Strategies · Cardiovascular/Vascular · Diabetes · Digital Health · Executive Interviews · Investors & Dealmaking
“Neuro-Diagnostics – Managing Concussion: Sports and Device Industries Collaborate to Bring New Technologies to Fruition,” by Mary Thompson
Article Categories:Biopharma/Biomaterials · Business Strategies · Cardiovascular/Vascular · Diabetes · Digital Health · Executive Interviews · Investors & Dealmaking
“Commercial Strategies – Cerapedics: A PMA First Opens Up New Opportunities in Cervical Spine Osteobiologics,” by Wendy Diller
Article Categories:Biopharma/Biomaterials · Business Strategies · Cardiovascular/Vascular · Diabetes · Digital Health · Executive Interviews · Investors & Dealmaking
“Outside Opinion – When Considering a Merger, Ask Why,” by Brian Chapman and Matt Scheitlin, ZS Associates
Article Categories:Biopharma/Biomaterials · Business Strategies · Cardiovascular/Vascular · Diabetes · Digital Health · Executive Interviews · Investors & Dealmaking